Axonics to Report First Quarter 2023 Financial Results on May 1
10 April 2023 - 8:00PM
Business Wire
Axonics, Inc. (Nasdaq: AXNX), a global medical technology
company that is developing and commercializing novel products for
the treatment of bladder and bowel dysfunction, is scheduled to
report first quarter 2023 financial results after the close of
trading on Monday, May 1.
Axonics will host a conference call at 4:30 p.m. Eastern Time to
discuss financial results. To access the conference call by
telephone, interested parties may register at the following link:
Axonics 1Q23 registration.
For those not planning to ask a question, the company recommends
accessing the conference call by webcast at the following link:
Axonics 1Q23 webcast. A replay of the webcast will be archived in
the Events section of the Axonics investor relations website.
About Axonics
Axonics is a global medical technology company that is
developing and commercializing novel products for adults with
bladder and bowel dysfunction. Axonics recently ranked No. 2 on the
2023 Financial Times ranking of the fastest growing companies in
the Americas and No. 4 on the 2022 Deloitte Technology Fast
500.
Axonics® sacral neuromodulation systems provide adults with
overactive bladder and/or fecal incontinence with long-lived, easy
to use, safe, clinically effective therapy. In addition, the
company’s best-in-class urethral bulking hydrogel, Bulkamid®,
provides safe and durable symptom relief to women with stress
urinary incontinence. In the U.S., moderate to severe urinary
incontinence affects an estimated 28 million women and fecal
incontinence affects an estimated 19 million adults. Axonics’
clinically proven products are offered at hundreds of medical
centers across the U.S. and abroad. Reimbursement coverage is well
established in the U.S. and is a covered service in most European
countries. For more information, visit www.axonics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230410005145/en/
Axonics contact: Neil Bhalodkar 949-336-5293
IR@axonics.com
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Apr 2023 to Apr 2024